Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter, Lantheus.

Med-tech firms raising money in public or private financings, including: Mobileodt, Neovasc, Reify Health, Pacific Biosciences of California, Personalis, Quanterix.

New hires and promotions in the med-tech industry, including: Bioventrix, Dexcom, Inteliquet, Kane Biotech, Portal Innovations, Wavefront Dynamics, Wishbone Medical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akoya Biosciences, Beroni Group, Biodesix, Biotricity, Caregility, Cdx Diagnostics, Celltrion, Dartmouth-Hitchcock Health, Datanet Software Development, Epic Systems, Genedx, Moleculight, Genscript Biotech, Health Catalyst, Imricor, Iron Bow Healthcare Solutions, Itoco, Monopar, Nexstim, Pediatrix, Sherlock Biosciences, Tabula Rasa, Vitalware.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akari, Arca, Ascendis, Eli Lilly, Epirium, Eyegate, Indian, Innovent, Kahr, Kineta, Pliant, Redhill, Regeneron, Seattle Genetics, Theranexus.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beroni, Beyondspring, Caribou, Cytovia, Fibrogenesis, Genecentric, Genscript, Helix, Hepion, Ikena, Itrom, Janssen, Mammoth, Monopar, Nicox, Novome, Proteonic, Therapeutics Solutions.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Azurrx, Blade, Boehringer, Botanix, Eloxx, Epirium, Nektar, Sapience, Vaccibody, VBL.

Biopharmas raising money in public or private financings, including: Adverum, Horizon, Inhibrx, Nymox, Omeros, Seres, Trevena.

New hires and promotions in the biopharma industry, including: Bellerophon, Kamada, Werewolf.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ana, Anavex Life Sciences, Appili, Biogen, Biophytis, Canbridge, Cytodyn, Deciphera, Diurnal, Eisai, Gilead Sciences, Hutchison China Meditech, I-Mab, Kazia, Neurorx, Organicell Regenerative Medicine, Pluristem, Redhill, Relief, Revive, Vaxart.